The Cellular Imaging Shared Resource (CISR) provides Consortium members with a comprehensive set of advanced high resolution imaging techniques, quantitative gel and blot imaging, and quantitative image analysis for cancer research. The resource is comprised of two service-based laboratories, Electron Microscopy (EM) and Scientific Imaging (SI). The EM laboratory offers sample preparation, access to microtomy, cryo- and immuno- EM technologies, and training in transmission and scanning EM, and atomic force microscopy. The SI laboratory provides access to advanced imaging systems for confocal, deconvolution, multi photon, time lapse, total internal reflection fluorescence, high content analysis, whole slide scanning, and other light microscopy techniques, along with powerful software for visualization and quantitative analysis of microscopy data. As research needs and priorities evolve, CI has expanded into new areas to provide support for a broader range of investigator and research programs. Examples of new services include: high content analysis and plate screening; whole slide scanning and analysis; and Cryo and Immuno-EM. Overall, all Consortium research programs currently use the resource and both components provide essential services and technologies for member research. The resource constantly evaluates new technologies and the benefits they can bring to the Consortium, and actively promotes the use of such technologies through classes, workshops, seminars, and one-on-one discussions with individual researchers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA015704-40
Application #
8804778
Study Section
Subcommittee G - Education (NCI)
Project Start
2015-02-01
Project End
2019-12-31
Budget Start
2015-02-01
Budget End
2015-12-31
Support Year
40
Fiscal Year
2015
Total Cost
$81,945
Indirect Cost
$32,365
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Yeung, Cecilia C S; McElhone, Scott; Chen, Xue Yan et al. (2018) Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome. Mod Pathol 31:569-580
Leger, Kasey J; Baker, K Scott; Cushing-Haugen, Kara L et al. (2018) Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation. Cancer 124:1507-1515
Ranola, John Michael O; Pearlman, Rachel; Hampel, Heather et al. (2018) Modified capture-recapture estimates of the number of families with Lynch syndrome in Central Ohio. Fam Cancer :
Dai, James Y; Liang, C Jason; LeBlanc, Michael et al. (2018) Case-only approach to identifying markers predicting treatment effects on the relative risk scale. Biometrics 74:753-763
Huang, Yijian; Wang, Ching-Yun (2018) Cox regression with dependent error in covariates. Biometrics 74:118-126
Boucoiran, Isabelle; Mayer, Bryan T; Krantz, Elizabeth M et al. (2018) Nonprimary Maternal Cytomegalovirus Infection After Viral Shedding in Infants. Pediatr Infect Dis J 37:627-631
Hempstead, Bridgette; Green, Cynthia; Briant, Katherine J et al. (2018) Community Empowerment Partners (CEPs): A Breast Health Education Program for African-American Women. J Community Health 43:833-841
OhAinle, Molly; Helms, Louisa; Vermeire, Jolien et al. (2018) A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV. Elife 7:
Syrjala, Karen L; Yi, Jean C; Artherholt, Samantha B et al. (2018) An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation. J Cancer Surviv 12:560-570
Liu, Yang; He, Qianchan; Sun, Wei (2018) Association analysis using somatic mutations. PLoS Genet 14:e1007746

Showing the most recent 10 out of 1267 publications